These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 24685878)

  • 21. Patient-reported multiple drug reactions: clinical profile and results of challenge testing.
    Ramam M; Bhat R; Jindal S; Kumar U; Sharma VK; Sagar R; Chadda RK
    Indian J Dermatol Venereol Leprol; 2010; 76(4):382-6. PubMed ID: 20657119
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cutaneous adverse reactions following the administration of nonsteroidal antiinflammatory drugs and antibiotics: an Italian survey.
    Bottoni A; Criscuolo D
    Int J Clin Pharmacol Ther Toxicol; 1992 Jul; 30(7):257-9. PubMed ID: 1387114
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinico-mycological study of dermatophytes in a tertiary care centre in Northwest India.
    Agarwal US; Saran J; Agarwal P
    Indian J Dermatol Venereol Leprol; 2014; 80(2):194. PubMed ID: 24685877
    [No Abstract]   [Full Text] [Related]  

  • 24. A retrospective study of mortality of pemphigus patients in a tertiary care hospital.
    Nair SP
    Indian J Dermatol Venereol Leprol; 2013; 79(5):706-9. PubMed ID: 23974590
    [No Abstract]   [Full Text] [Related]  

  • 25. Cutaneous adverse drug reactions in children. A series of 90 cases.
    Khaled A; Kharfi M; Ben Hamida M; El Fekih N; El Aidli S; Zeglaoui F; Ezzine N; Fazaa B; Kamoun MR
    Tunis Med; 2012 Jan; 90(1):45-50. PubMed ID: 22311448
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Phenylbutazone and DRESS syndrome].
    Schmutz JL; Barbaud A; Trechot P
    Ann Dermatol Venereol; 2010 Dec; 137(12):857. PubMed ID: 21134594
    [No Abstract]   [Full Text] [Related]  

  • 27. [Adverse cutaneous reactions to drugs among hospitalized patients: a one year surveillance].
    Danza A; López M; Vola M; Alvarez-Rocha A
    Rev Med Chil; 2010 Nov; 138(11):1403-9. PubMed ID: 21279253
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cutaneous adverse drug reactions in a hospital-based Chinese population.
    Huang HY; Luo XQ; Chan LS; Cao ZH; Sun XF; Xu JH
    Clin Exp Dermatol; 2011 Mar; 36(2):135-41. PubMed ID: 20738322
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [DRESS syndrome].
    Khaled A; Souissi A; Zeglaoui F; El Fekih N; Daghfous R; Fazaa B
    Tunis Med; 2012 Oct; 90(10):749-51. PubMed ID: 23096521
    [No Abstract]   [Full Text] [Related]  

  • 30. [Skin pathology caused by drugs].
    Lodi A; Betti R; Masnada MC; Chiarelli G; Cattaneo M
    Minerva Med; 1985 Nov; 76(42):1991-4. PubMed ID: 2933598
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of patch testing in antimicrobial drug eruptions.
    Grandhe NP; Kaur I; Parsad D; Dogra S
    Contact Dermatitis; 2004 Apr; 50(4):259-61. PubMed ID: 15186393
    [No Abstract]   [Full Text] [Related]  

  • 32. [Fixed drug eruption in dermatology setting in Lomé (Togo): a retrospective study of 321 cases].
    Saka B; Kombaté K; Médougou BH; Akakpo S; Mouhari-Toure A; Boukari T; Tchangaï-Walla K; Pitché P
    Bull Soc Pathol Exot; 2012 Dec; 105(5):384-7. PubMed ID: 22669581
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oral drug provocation test to generate a list of safe drugs: experience with 100 patients.
    Ramam M; Kumar U; Bhat R; Sharma VK
    Indian J Dermatol Venereol Leprol; 2012; 78(5):595-8. PubMed ID: 22960815
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Rate of cutaneous drug hypersensitivity].
    Adam H
    Allerg Immunol (Leipz); 1972; 18(2):73-80. PubMed ID: 4266964
    [No Abstract]   [Full Text] [Related]  

  • 35. Drug-induced urticaria: causes and clinical courses.
    Rutnin NO; Kulthanan K; Tuchinda P; Jongjarearnprasert K
    J Drugs Dermatol; 2011 Sep; 10(9):1019-24. PubMed ID: 22052271
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comprehensive 4-year survey of adverse drug reactions using a network-based hospital system.
    Chen CJ; Cheng CF; Lin HY; Hung SP; Chen WC; Lin MS
    J Clin Pharm Ther; 2012 Dec; 37(6):647-51. PubMed ID: 22646235
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Occupationally induced fixed drug eruption caused by a non-steroidal anti-inflammatory agent.
    Lamchahab F; Baeck M
    Contact Dermatitis; 2012 Sep; 67(3):176-7. PubMed ID: 22897784
    [No Abstract]   [Full Text] [Related]  

  • 38. Fixed drug eruption: primary site involvement on maximal points of Head's zones.
    Ozkaya E
    Acta Derm Venereol; 2007; 87(6):517-20. PubMed ID: 17989890
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug allergy.
    Dykewicz MS
    Compr Ther; 1996 Jun; 22(6):353-9. PubMed ID: 8814383
    [No Abstract]   [Full Text] [Related]  

  • 40. Oral challenge in patients with suspected cutaneous adverse drug reactions: findings in 784 patients during a 25-year-period.
    Lammintausta K; Kortekangas-Savolainen O
    Acta Derm Venereol; 2005; 85(6):491-6. PubMed ID: 16396795
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.